mofebutazone

Independent reference data for mofebutazone (CAS 2210-63-1), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.M02 - Topical products for joint and muscular pain

Synonyms and trade names

Mofebutazone; 2210-63-1; 4-butyl-1-phenylpyrazolidine-3,5-dione; Monophenylbutazone; Mophebutazone; 2 Fdbp; Mofebutazona; Mofebutazonum; Monazone; 4-Butyl-1-phenyl-3,5-pyrazolidinedione; 4-Butyl-1-phenyl-3,5-dioxopyrazolidine; SPW36WUI5Z; 2-Phenyl-3,5-dihydroxy-4-butylpyrazolidine; NSC-73725; DTXSID4023331; CHEBI:76252

GHS hazard classification

Reported hazard statements	H302 (100%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

What the public record says

mofebutazone · CAS 2210-63-1 · C13H16N2O2. UNII SPW36WUI5Z.

Source: PubChem / Wikidata; the batch COA governs where values differ.